FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

FDA Says Looking at Safety of RSV Infant Therapies

FDA advises the companies manufacturing RSV therapies for infants that the agency is taking a new look at the therapies safety.

latest-news-card-1
Medical Devices

Envoy Medical QS Violations

FDA warns Saint Paul, MN-based Envoy Medical about Quality System violations in its manufacturing of the Esteem II implantable hearing system.

Biologics

FDA Broadens Covid Vaccine Probe to Include Adult Deaths

FDA opens a broad investigation into reports of deaths in adults that may be linked to Covid-19 vaccines after probing pediatric deaths allegedly tied...

FDA General

Experts Call for Overhaul of FDA Revolving Door Rules

Two pharmacist-attorneys (BakerHostetler) urge Congress to strengthen federal restrictions on how senior FDA officials move into private-sector roles,...

latest-news-card-1
Medical Devices

Draeger Recalls Airway Catheter Mount

Draeger recalls (Class 1) its ErgoStar CM 60 (catheter mount 60), an airway connector/catheter mount, after receiving multiple complaints reporting de...

latest-news-card-1
Human Drugs

Prescription to Nonprescription Switch MAPP

CDER issues a Manual of Policies and Procedures for when a reference-listed drug switches from prescription to nonprescription marketing status and AN...

latest-news-card-1
Biologics

FDA Raises Approval Standards for CAR-T Cancer Therapies

CBER officials pen a new JAMA article signaling a major policy shift for cancer CAR T-cell therapies, moving away from reliance on single-arm studies ...

latest-news-card-1
Human Drugs

Potential Redefinition of Enforcement Boundaries: Attorneys

Four Hogan Lovells attorneys describe a potential significant shift in Justice Department enforcement boundaries, especially involving off-label presc...

latest-news-card-1
Human Drugs

CGMP Issues at Seaway Pharma

FDA warns Massena, NY-based Seaway Pharma about long-standing CGMP violations in its production of finished drugs as a contract manufacturer.

latest-news-card-1
Human Drugs

First Approval Under New Priority Voucher Program

FDA approves Augmentin XR (amoxicillinclavulanate potassium) through the new Commissioners National Priority Voucher pilot program, permitting new U.S...